(Q57903192)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22793378%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

title

Limited-stage mantle cell lymphoma: treatment outcomes at the Princess Margaret Hospital (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22793378%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22793378%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

author name string

Maryse Bernard

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22793378%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Alexander Sun

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22793378%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Woody Wells

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22793378%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Vishal Kukreti

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22793378%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

John Kuruvilla

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22793378%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Michael Crump

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22793378%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Lisa W Le

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22793378%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

David C Hodgson

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22793378%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Mary K Gospodarowicz

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22793378%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

publication date

10 September 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22793378%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22793378%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

volume

54

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22793378%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22793378%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

page(s)

261-267

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22793378%20AND%20SRC:MED&resulttype=core&format=json

European Lymphoma Task Force (ELTF): Report of the workshop on Mantle Cell Lymphoma (MCL)

7 February 2020

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.711828

Molecular remission is an independent predictor of clinical outcome in patients with mantle cell lymphoma after combined immunochemotherapy: a European MCL intergroup study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.711828

Ki-67 predicts outcome in advanced-stage mantle cell lymphoma patients treated with anti-CD20 immunochemotherapy: results from randomized trials of the European MCL Network and the German Low Grade Lymphoma Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.711828

How I treat mantle cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.711828

Ki-67 as a prognostic marker in mantle cell lymphoma-consensus guidelines of the pathology panel of the European MCL Network

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.711828

Limited-stage mantle-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.711828

Lymphoid lesions of the head and neck: a model of lymphocyte homing and lymphomagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.711828

A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.711828

Therapeutic options in mantle cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.711828

Immunochemotherapy with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone significantly improves response and time to treatment failure, but not long-term outcome in patients with previously untreated mantle cell lymphoma: res

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.711828

Improvement of Overall Survival in Advanced Stage Mantle Cell Lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.711828

Outcome of deferred initial therapy in mantle-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.711828

The Mantle Cell Lymphoma International Prognostic Index (MIPI) is superior to the International Prognostic Index (IPI) in predicting survival following intensive first-line immunochemotherapy and autologous stem cell transplantation (ASCT).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.711828

Histopathology, cell proliferation indices and clinical outcome in 304 patients with mantle cell lymphoma (MCL): a clinicopathological study from the European MCL Network

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.711828

The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.711828

Five-gene model to predict survival in mantle-cell lymphoma using frozen or formalin-fixed, paraffin-embedded tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.711828

Phase II study of oral vinorelbine in first-line advanced breast cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.711828

Comparative outcome of initial therapy for younger patients with mantle cell lymphoma: an analysis from the NCCN NHL Database

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.711828

Multiple molecular mechanisms contribute to radiation sensitivity in mantle cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.711828

Highly effective local control and palliation of mantle cell lymphoma with involved-field radiation therapy (IFRT).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.711828

Immunochemotherapy with rituximab and overall survival in patients with indolent or mantle cell lymphoma: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.711828

10.3109/10428194.2012.711828

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22793378%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

1 reference